Telemedicine and Nursing Home

Impact of Telemedicine on Avoiding Emergency Hospital Admissions and Hospitalization for Nursing Home Residents

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02816177

Acronym

GERONTACCESS

Enrollment

428

Registered

2016-06-28

Start date

2016-07-05

Completion date

2019-06-30

Last updated

2025-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elderly, Multimorbidity

Brief summary

Telemedicine-based care provides remote health and social care to maintain people's autonomy and increase their quality of life. The rapidly aging population has come with a significant increase in the prevalence of chronic diseases and their effects, and thus the need for increased care and welfare. This solutions give a new opportunity for diagnosis, treatment, education, and rehabilitation, and make it possible to monitor patients with a number of chronic diseases. It also reduces socioeconomic disparity with regard to access to care and gives equal chances to patients from urban and rural areas. This a randomized trial of telemedicine versus usual care alone to reduce hospitalization and emergency hospital admissions for Nursing Home Residents . After an initial assessment , each participant is monitored by teleconsultation on six occasions over 12 months. Patients with usual care have an initial and a 12 months assessments.

Interventions

OTHERTelemedicine

OTHERUsual Care

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

60 Years to No maximum

Healthy volunteers

Inclusion criteria

* Elderly over 60 years * Resident in nursing homes * Resident with multiples chronic diseases with at least two comorbidities * Having given free and informed consent in writing and signed by himself and / or his legal representative

Exclusion criteria

* Resident unaffiliated or not beneficiary of Social Security * Resident with a life-threatening disease

Design outcomes

Primary

Measure	Time frame	Description
Efficacy	12 month	Proportion of patients who had an admission to the emergency or unscheduled hospitalization in health service or surgery

Secondary

Measure	Time frame	Description
MAST	12 months	Cost / effectiveness of telemedicine based on the MAST model (Model of Assessment of Telemedicine ).

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026